Medicofarma Biotech SA, formerly InBook SA, is a Poland-based biotechnology company. It is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-09 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
26-11-04	PLN 0.3820	+3.80%	16,772
26-11-03	PLN 0.3680	-1.60%	8,742
26-11-02	PLN 0.3740	0.00%	2,444
26-10-30	PLN 0.3740	+2.75%	4,955
26-10-29	PLN 0.3640	+8.33%	27,812

Delayed Quote Warsaw S.E.

More quotes

Market Closed - Warsaw S.E. 10:59:59 2026-11-04 EST			5-day change	1st Jan Change
0.3680 ^PLN	-0.54%		+8.24%	-7.77%

08-14	Medicofarma Biotech SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	25.97M 6.65M 5.93M 5.43M 4.95M 9.3M 629M 9.5M 64.75M 333M 24.96M 24.44M 1.06B	P/E 2024	-11.5x	P/E 2025	-12.2x
Enterprise Value	29.67M 7.6M 6.77M 6.21M 5.65M 10.63M 719M 10.85M 73.99M 381M 28.53M 27.92M 1.21B	EV / Sales 2024	23.6x	EV / Sales 2025	257x
Free-Float	20.34%	Yield 2024 *	-	Yield 2025	-

08-14	Medicofarma Biotech SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-22	Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-10	Medicofarma Biotech SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-07	Medicofarma Biotech SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-06-05	Medicofarma Biotech SA Auditor Raises 'Going Concern' Doubt	CI
25-05-12	Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-02-13	Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-11-13	Medicofarma Biotech SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-08-14	Medicofarma Biotech SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-05-13	Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-02-06	Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-02-06	Medicofarma Biotech SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

1 day	-0.54%
1 week	+8.24%
Current month	-1.60%
1 month	-5.64%
3 months	-4.66%
6 months	-22.36%
Current year	-7.77%

Medicofarma Biotech SA Stock

Stocks

MDB

PLINBOK00010

Biotechnology & Medical Research

Valuation: Medicofarma Biotech SA

Chart: Medicofarma Biotech SA

Latest news: Medicofarma Biotech SA

Press Releases: Medicofarma Biotech SA

Quotes and Performance

Price Extremes

Managers and Directors: Medicofarma Biotech SA

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

1 week	0.33	0.39
1 month	0.29	0.41
Current year	0.29	0.64
1 year	0.29	0.64
3 years	0.23	1.4
5 years	0.23	2.3
10 years	0.18	8.5

Manager	Title	Age	Since
Robert Kilczewski Cezary CEO	Chief Executive Officer	-	-
Michal Szarycz IRC	Investor Relations Contact	-	-

Director	Title	Age	Since
Piotr Zawadzki CHM	Chairman	-	-
Piotr Bielecki BRD	Director/Board Member	-	-
Alicja Jablonska BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEDICOFARMA BIOTECH SA	-0.54%	+8.24%	-29.50%	-67.72%	6.35M
WUXI APPTEC CO., LTD.	+10.00%	+5.18%	+54.35%	+71.20%	60.57B
LONZA GROUP AG	+1.44%	+4.06%	+22.70%	+101.03%	55.51B
ARGENX SE	+3.32%	+4.11%	+14.82%	+75.04%	55.22B
IQVIA HOLDINGS INC.	+0.46%	-2.86%	+23.34%	+33.77%	43.27B
BEONE MEDICINES AG	+6.42%	+3.20%	+21.14%	+105.56%	40.36B
REVOLUTION MEDICINES, INC.	+2.82%	+7.24%	+236.59%	+801.17%	41.63B
GENMAB A/S	-3.79%	+19.39%	+91.90%	+77.13%	33.29B
CELLTRION, INC.	+5.32%	+6.04%	+20.27%	+52.98%	32.27B
INSMED INCORPORATED	+5.32%	+15.84%	-40.93%	+342.66%	22.91B
Average	+3.08%	+5.15%	+41.47%	+159.28%	38.5B
Weighted average by Cap.	+3.72%	+4.06%	+51.58%	+169.51%

	2024	2025
Net sales	1.22M 314K 280K 256K 233K 439K 29.68M 448K 3.05M 15.72M 1.18M 1.15M 49.77M	120K 30.72K 27.36K 25.09K 22.84K 42.95K 2.9M 43.85K 299K 1.54M 115K 113K 4.87M
Net income	-2.3M -590K -525K -481K -438K -824K -55.74M -841K -5.74M -29.53M -2.21M -2.16M -93.48M	-2.23M -572K -509K -467K -425K -799K -54.04M -816K -5.56M -28.63M -2.14M -2.1M -90.63M
Net Debt	2.53M 648K 577K 529K 481K 905K 61.23M 924K 6.3M 32.44M 2.43M 2.38M 103M	3.71M 950K 846K 775K 706K 1.33M 89.8M 1.36M 9.24M 47.57M 3.56M 3.49M 151M